What Patients & Families Need to Know | New Visitor Policy | Guidance for Community Healthcare Providers
Director of Research, Division of Developmental and Behavioral Pediatrics
Associate Professor, UC Department of Pediatrics
Tanya Froehlich, MD, MS, is a developmental-behavioral pediatrician whose research focuses on attention-deficit/hyperactivity disorder (ADHD). Her publications have investigated the prevalence of ADHD, ADHD medication use, and preschool psychotropic medication use. She also studies the contribution of environmental exposures (e.g., lead, tobacco, and pesticides) to ADHD etiology, and has served as co-investigator on a National Institute of Environmental Health Sciences R01 grant examining the effects of pyrethroid pesticide exposure on ADHD symptoms. In addition, Dr. Froehlich is working to identify predictors of ADHD medication response, and received a National Institute of Mental Health (NIMH) K23 Award to investigate this topic. Currently, she is the principal investigator on an NIMH-funded R01 aimed at characterizing effects of abrupt methylphenidate discontinuation, including evaluating genetic and phenotypic moderators of effect.
In addition, Dr. Froehlich has a strong interest in interprofessional training and mentoring. She is site principal investigator for a state-funded grant whose mission is train professionals from a variety of disciplines to provide enhanced care for families on Ohio Medicaid, with a special emphasis on care of developmental and mental health conditions. Dr. Froehlich is also supervisor for a Leadership Education in Neurodevelopmental Disabilities (LEND) interdisciplinary project which focuses on elucidating the needs of families in homeless shelters. Furthermore, Dr. Froehlich serves as associate director of the Developmental and Behavioral Pediatrics Fellowship as well as the director of research training for the Cincinnati Children’s Division of Developmental and Behavioral Pediatrics.
Developmental and Behavioral Pediatrics, Autism, Attention Deficit Hyperactivity Disorder ADHD, Developmental and Behavioral Pediatrics, Attention Deficit Hyperactivity Disorder ADHD
By Tanya Froehlich, MD10/3/2017
Tanya Elizabeth Froehlich, MD, MS, FAAP1/31/2020
MD: Yale University School of Medicine, 1999.
MS: Epidemiology, University of Cincinnati, 2007.
Pediatric Intern: Children’s Hospital of Philadelphia, 1999-2000.
Pediatric Resident: Children’s Hospital of Philadelphia, 2000-2002.
Fellowship: Developmental and Behavioral Pediatrics, Cincinnati Children’s Hospital Medical Center, 2002-2005; General Pediatrics National Research Service Award Fellow, Cincinnati Children’s Hospital Medical Center, 2004-2007.
Factors Associated with Attention Deficit Hyperactivity Disorder Medication Use in Community Care Settings.
Kamimura-Nishimura, KI; Epstein, JN; Froehlich, TE; Peugh, J; Brinkman, WB; Baum, R; Gardner, W; Langberg, JM; Lichtenstein, P; Chen, D; et al.
The Journal of Pediatrics.
Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents.
Wolraich, ML; Allan, C; Chan, E; Davison, D; Earls, M; Evans, SW; Flinn, SK; Froehlich, T; Frost, J; Holbrook, JR; et al.
ADHD diagnosis and treatment guidelines: A historical perspective.
Wolraich, ML; Chan, E; Froehlich, T; Lynch, RL; Bax, A; Redwine, ST; Ihyembe, D; Jr, HJ F.
Strategies for improving ADHD medication adherence.
Kamimura-Nishimura, KI; Brinkman, WB; Froehlich, TE.
Attention-Deficit/Hyperactivity Disorder-Related Deficits and Psychostimulant Medication Effects on Comprehension of Audiovisually Presented Educational Material in Children.
Orban, SA; Karamchandani, TA; Tamm, L; Sidol, CA; Peugh, J; Froehlich, TE; Brinkman, WB; Estell, N; Mii, AE; Epstein, JN.
Journal of Child and Adolescent Psychopharmacology.
Schumacher, J; Froehlich, T. In: Zuckerman B; Augustyn M, Ed.
Zuckerman Parker Handbook of Developmental and Behavioral Pediatrics for Primary Care.
Philadelphia, PA: LWW;
Using ADHD Medications to Treat Coexisting ADHD and Reading Disorders: A Systematic Review.
Froehlich, TE; Fogler, J; Barbaresi, WJ; Elsayed, NA; Evans, SW; Chan, E.
Clinical Pharmacology and Therapeutics.
Sluggish Cognitive Tempo as a Possible Predictor of Methylphenidate Response in Children With ADHD: A Randomized Controlled Trial.
Froehlich, TE; Becker, SP; Nick, TG; Brinkman, WB; Stein, MA; Peugh, J; Epstein, JN.
Journal of Clinical Psychiatry.
Multimodal Treatment of the School-aged Child With Attention-Deficit/Hyperactivity Disorder.
Froehlich, TE; Brinkman, WB.
ADHD Medication Adherence in College Students - A Call to Action for Clinicians and Researchers: Commentary on "transition to College and Adherence to Prescribed Attention Deficit Hyperactivity Disorder Medication ".
Journal of Developmental and Behavioral Pediatrics.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462
© 1999-2020 Cincinnati Children's Hospital Medical Center. All rights reserved.